SINGAPORE, June 30, 2016 /CNW/ - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F, OTCPK: ZMSPF), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that it has received a second order for its patented Lutetium Fine Silicate (LFS) scintillation crystals from the same major OEM developing radiation monitoring and detection devices. This follows the initial order for LFS crystals previously announced on April 1, 2016 whereby the LFS crystals were tested in a device for large cargo screening at land crossings such as border crossings, airports, and harbours. The second order of LFS crystals are to be tested for screening applications for luggage, bags, packages, for high security locations including government buildings, sports stadiums, conventions centers and other crowded venues.
"The illegal trafficking of radioactive materials is a serious concern for governments around the world and our patented LFS scintillation crystal is ideal for identifying even the smallest amount of material in a large area," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. "This order of LFS crystals has been specifically produced for use in devices that will provide quick and effective scanning of a large number of people. The scanning device will have the capacity for significant throughput with superior imaging performance and high resolution images. Our crystals have higher spectroscopic resolution and a decay constant that is 10 times faster and more accurate than competing crystals. We are working closely with the device manufacturer to develop detection devices for various applications and look to develop these crystal orders into long term, high volume contracts."
The increasing threat of nuclear terrorism has contributed to the significant growth of the overall radiation safety market. Governments and private businesses need a radiation detection solution that is reliable and easy to implement. A scintillation detection system consists of scintillation crystals, photo detectors, an electric signal and processing electronics. The systems can be made quite large and used in radiation detection, assay of radioactive materials and physics research. They are less expensive to implement, have very reliable quantum efficiency and can measure both the intensity and the energy of incident radiation.
Radiation detection represents a sizeable market opportunity for Zecotek. Industry experts predict that the market for instruments specifically designed to measure radiation is estimated to grow to US$3.5 billion by 2022. The addition of medical imaging equipment and high energy physics brings the total market to over US$25 billion and growing.
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, 3D metal printing, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Optronics Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners including Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center (South Korea). For more information visit www.zecotek.com, and follow @zecotek on Twitter.
This press release may contain forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.
For further information: Zecotek Photonics Inc., Michael Minder, T: (604) 783-8291, email@example.com